Radiopharm Theranostics
Sydney, New South Wales, Australia · Biotechnology, Health Care, Medical · 14 employees
Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
Funding history
- Funding Round — $35.0M — Oct 2025
Recent signals
- Jun 01, 2026: Radiopharm Theranostics Appoints Aaron Laurita as Chief Financial Officer
- Oct 20, 2025: Raised $35.0M
- Oct 21, 2024: Radiopharm Theranostics partners with BAMF Health for brain cancer study
See plans & pricing → Track Radiopharm Theranostics’s funding, hiring, and signals — with verified contacts — on Fundz.